Mercialys Valuation
Is MERYP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MERYP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MERYP (€10.54) is trading below our estimate of fair value (€16.7)
Significantly Below Fair Value: MERYP is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MERYP?
Key metric: As MERYP is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
What is MERYP's PE Ratio? | |
---|---|
PE Ratio | 16.8x |
Earnings | €59.18m |
Market Cap | €991.49m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 12.6x |
Enterprise Value/EBITDA | 17.2x |
PEG Ratio | 1.2x |
Price to Earnings Ratio vs Peers
How does MERYP's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 64.9x | ||
NRR NewRiver REIT | 95.4x | 33.0% | UK£286.3m |
CAL Capital & Regional | 69.8x | 47.8% | UK£146.5m |
SHC Shaftesbury Capital | 64.5x | 28.4% | UK£2.4b |
UKCM UK Commercial Property REIT | 29.9x | n/a | UK£947.3m |
MERYP Mercialys | 16.8x | 13.5% | €991.5m |
Price-To-Earnings vs Peers: MERYP is good value based on its Price-To-Earnings Ratio (16.8x) compared to the peer average (64.9x).
Price to Earnings Ratio vs Industry
How does MERYP's PE Ratio compare vs other companies in the European Retail REITs Industry?
0 Companies | Price / Earnings | Estimated Growth | Market Cap |
---|---|---|---|
0 Companies | Estimated Growth | Market Cap |
---|
Price-To-Earnings vs Industry: MERYP is good value based on its Price-To-Earnings Ratio (16.8x) compared to the European Retail REITs industry average (21.6x).
Price to Earnings Ratio vs Fair Ratio
What is MERYP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 16.8x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MERYP's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | €10.54 | €12.92 +22.6% | 6.1% | €14.50 | €12.50 | n/a | 5 |
Nov ’25 | €10.72 | €12.92 +20.6% | 6.1% | €14.50 | €12.50 | n/a | 5 |
Oct ’25 | €12.12 | €12.58 +3.8% | 4.1% | €13.50 | €11.90 | n/a | 5 |
Sep ’25 | n/a | €12.40 0% | 6.8% | €13.50 | €11.10 | n/a | 5 |
Aug ’25 | n/a | €12.40 0% | 6.8% | €13.50 | €11.10 | n/a | 5 |
Jul ’25 | n/a | €11.45 0% | 3.1% | €12.00 | €11.10 | n/a | 4 |
Jun ’25 | €11.40 | €11.70 +2.6% | 3.1% | €12.10 | €11.20 | n/a | 4 |
May ’25 | n/a | €11.70 0% | 3.1% | €12.10 | €11.20 | n/a | 4 |
Apr ’25 | n/a | €11.70 0% | 3.1% | €12.10 | €11.20 | n/a | 4 |
Mar ’25 | €10.28 | €11.45 +11.4% | 3.7% | €12.00 | €10.80 | n/a | 4 |
Feb ’25 | n/a | €11.46 0% | 3.3% | €12.00 | €10.80 | n/a | 5 |
Jan ’25 | n/a | €10.50 0% | 13.0% | €12.00 | €8.50 | n/a | 4 |
Dec ’24 | n/a | €10.50 0% | 13.0% | €12.00 | €8.50 | n/a | 4 |
Nov ’24 | n/a | €11.17 0% | 7.6% | €12.00 | €10.00 | €10.72 | 3 |
Oct ’24 | n/a | €11.17 0% | 7.6% | €12.00 | €10.00 | €12.12 | 3 |
Sep ’24 | n/a | €10.57 0% | 16.0% | €12.00 | €8.20 | n/a | 3 |
Aug ’24 | n/a | €10.57 0% | 16.0% | €12.00 | €8.20 | n/a | 3 |
Jul ’24 | n/a | €9.85 0% | 16.8% | €11.50 | €8.20 | n/a | 2 |
Jun ’24 | €7.49 | €10.85 +44.9% | 6.0% | €11.50 | €10.20 | €11.40 | 2 |
May ’24 | €8.85 | €10.85 +22.7% | 6.0% | €11.50 | €10.20 | n/a | 2 |
Apr ’24 | n/a | €11.35 0% | 1.3% | €11.50 | €11.20 | n/a | 2 |
Mar ’24 | €10.38 | €11.35 +9.3% | 1.3% | €11.50 | €11.20 | €10.28 | 2 |
Feb ’24 | €10.19 | €10.75 +5.5% | 7.0% | €11.50 | €10.00 | n/a | 2 |
Jan ’24 | n/a | €10.75 0% | 7.0% | €11.50 | €10.00 | n/a | 2 |
Dec ’23 | €9.26 | €10.75 +16.2% | 7.0% | €11.50 | €10.00 | n/a | 2 |
Nov ’23 | n/a | €10.75 0% | 7.0% | €11.50 | €10.00 | n/a | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Cofinimmo
€2.2b
Cofinimmo has been acquiring, developing and managing rental properties for 40 years.
0J3X
€57.15
7D
-1.5%
1Y
-12.0%
Xior Student Housing
€1.3b
Xior Student Housing NV is the first Belgian public regulated real estate company (RREC) specialising in the student housing segment in Belgium, the Netherlands, Spain, Portugal, Germany, Poland, Denmark and Sweden.
0RD8
€30.25
7D
1.2%
1Y
-3.5%
Care Property Invest
€461.6m
Care Property Invest NV/SA is a Public Regulated Real Estate Company (public RREC) under Belgian law.
0R6H
€12.50
7D
1.1%
1Y
-4.0%